ACUT - Accustem Sciences Inc.
0.38
-0.100 -26.289%
Share volume: 3,566
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$0.48
-0.10
-0.21%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-20-2024 | 09-16-2024 | 11-18-2024 | 05-20-2025 | 11-12-2025 | |
| Assets | ||||||
| Total Assets | 50.941 K | 139.660 K | 103.819 K | 1.551 M | 1.573 M | |
| Current Assets | 47.801 K | 137.427 K | 102.494 K | 1.550 M | 1.573 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 1.500 M | 1.500 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.373 K | 46.072 K | 37.080 K | 36.381 K | 14.391 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.140 K | 2.233 K | 1.325 K | 105.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 50.941 K | 139.660 K | 103.819 K | 1.551 M | 1.573 M | |
| Total liabilities | 2.671 M | 3.024 M | 3.297 M | 3.707 M | 4.484 M | |
| Total current liabilities | 2.671 M | 3.024 M | 3.297 M | 3.707 M | 4.484 M | |
| Accounts Payable | 649.480 K | 744.693 K | 790.241 K | 849.071 K | 923.191 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -2.620 M | -2.884 M | -3.194 M | -2.157 M | -2.911 M | |
| Common stock | 4.429 M | 4.442 M | 4.461 M | 6.311 M | 6.358 M | |
| Retained earnings | -7.049 M | -7.327 M | -7.655 M | -8.467 M | -9.269 M |